ARCHIVES

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

This article is from The Cancer Letter archive.

Vol. 40 No. 22 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

General Says HHS Shift of Breast Cancer funds Could Leave Army in “Untenable Position”

March 12, 1993

ACS Recommends MRI For Some Women At High Risk

March 30, 2007

Pepper Committee, Impressed By Progress Reports, Promises Help With NCI Funding

June 29, 1979

Cancer Planners Revise Some Project Areas, Drop Some, Add New Ones

February 8, 1974

Letters: NCI Mammography Statement Recognizes Patient Autonomy

February 25, 1994

Research Contracts Branch Reorganized, Graalman On “Detail”

October 22, 1982